Trials / Unknown
UnknownNCT03492879
Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- Sponsor
- Prof. Ziv Ben-Ari MD · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of this study are to assess the performance of the non-invasive Electrical Impedance Technology (EIT) in evaluating the liver fibrosis stage in patients with chronic liver diseases, in comparisons with a liver biopsy and/or Shear wave elastography and Liver Ultrasonography. The second aim is comparing between Liver Ultrasonography and Electrical Impedance Technology (EIT) to quantify the hepatic steatosis grade in patients with Non Alcoholic Fatty Liver Disease (NAFLD) .
Detailed description
The study will include 210 patients with chronic liver diseases. Relevant clinical data such as sex, age, weight, height, alcohol intake, medical history and routine lab results will be collected. The study will include three groups: 1. Patients with indication for liver biopsy will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients). 2. Patients with chronic liver diseases will undergo routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients). 3. Patients with Non Alcoholic Fatty Liver Disease will undergo routine liver Ultrasonography, Shear wave elastography and quantification of liver steatosis using the Electrical Impedance Technology (EIT) (70 patients).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EIT Technology | Electrical Impedance Technology is a non-invasive imaging method who is being tested for evaluation of liver fibrosis stage |
Timeline
- Start date
- 2018-05-15
- Primary completion
- 2019-05-15
- Completion
- 2019-05-30
- First posted
- 2018-04-10
- Last updated
- 2018-04-10
Source: ClinicalTrials.gov record NCT03492879. Inclusion in this directory is not an endorsement.